Why is "Spinal muscular atrophy" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-04-06 08:05:14
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Spinal muscular atrophy (SMA) is a rare neuromuscular disorder that results in the loss of motor neurons and progressive muscle wasting. It is usually diagnosed in infancy or early childhood and if left untreated it is the most common genetic cause of infant death. It may also appear later in life and then have a milder course of the disease. The common feature is the progressive weakness of voluntary muscles, with the arm, leg, and respiratory muscles being affected first. Associated problems may include poor head control, difficulties swallowing, scoliosis, and joint contractures.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
FDA Approves Higher-Dose Regimen of Nusinersen for Spinal Muscular Atrophy - Pharmacy Times
-
Spinal Muscular Atrophy: A Disease of Both Muscles and Motor Neurons - European Medical Journal
-
Biogen Bounces Back With FDA Nod for High-Dose Spinal Muscular Atrophy Drug - BioSpace
-
FDA Approves High Dose Regimen of SPINRAZA® for Spinal Muscular Atrophy, Reflecting Progress Made Possible Through Decades of MDA Supported Research - Muscular Dystrophy Association
-
Targeted therapy improvements cap a decade of innovation in spinal muscular atrophy care - St. Jude Children's Research Hospital
-
High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial - Nature
-
Investigating New Treatments for Spinal Muscular Atrophy - Northwestern University
-
Scholar Rock Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA) - Business Wire
-
Risdiplam in Presymptomatic Spinal Muscular Atrophy - NEJM
-
When Spinal Muscular Atrophy Runs in the Family - HealthCentral
-
Jesy Nelson hails major milestone for SMA newborn screening - The Independent
-
Non–Cell-Autonomous Mechanisms and Systemic Interactions in Spinal Muscular Atrophy - ScienceDirect.com
-
New Promise in Spinal Muscular Atrophy - Johns Hopkins Medicine
-
One-Time Gene Therapy Itvisma Approved for Spinal Muscular Atrophy - Rheumatology Advisor
-
10H-phenothiazine exerts beneficial effects in spinal muscular atrophy in vitro and in vivo models - Nature
-
Clinical trial shows newborns with spinal muscular atrophy (SMA) can start treatment at birth - St. Jude Children's Research Hospital
-
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial - Nature
-
Targeted antisense oligonucleotide treatment rescues developmental alterations in spinal muscular atrophy organoids - Nature
-
A real-world, multicentre, epidemiological study in Czech and Slovak adults with spinal muscular atrophy treated with risdiplam - Nature
-
Munc13-1 restoration mitigates presynaptic pathology in spinal muscular atrophy - Nature
-
FDA Approves New Intrathecal Administration Route for Spinal Muscular Atrophy Gene Therapy - NeurologyLive
-
Immaturity of the neuromuscular junction in spinal muscular atrophy mouse models - Frontiers
-
Single dose of gene therapy to treat spinal muscular atrophy - Science Media Centre España
-
Novel In Utero Gene Therapy Holds Promise for Patients with Spinal Muscular Atrophy - Johns Hopkins Medicine
-
Biomarkers of immune dysregulation and posttreatment inflammation in spinal muscular atrophy - PNAS
-
Spinal Muscular Atrophy in Colombia: Nationwide Incidence, Demographic Distribution, and Healthcare Challenges - Cureus
-
Timing Is Everything – Emma’s Journey With Spinal Muscular Atrophy Type 1 - Seattle Children's
-
Neurodevelopmental and mental disorders in children with type I and presymptomatic spinal muscular atrophy - Nature
-
Modeling Spinal Muscular Atrophy to Identify a Promising Therapy - Stanford Medicine
-
Start Spinal Muscular Atrophy Treatment at Birth? - Medscape
-
Case Report: Spinal muscular atrophy with IgA nephropathy: a coincidence or association? - Frontiers
-
Spinal Muscular Atrophy (SMA): Steven's Story (Video) (for Teens) - Humana - South Carolina - KidsHealth
-
Muscle-Targeted Therapy Apitegromab Offers New Possibilities for Spinal Muscular Atrophy - neurologytoday.aan.com
-
Understanding the epidemiology of Spinal Muscular Atrophy - Clarivate
-
The effect of coadministration of D156844 and AR42 (REC-2282) on the survival and motor phenotype of mice with spinal muscular atrophy - Nature
-
Biogen to Advance Investigational Spinal Muscular Atrophy Asset to Registrational Studies Based on Positive Interim Phase 1 Results - Biogen
-
Presymptomatic treatment of spinal muscular atrophy with risdiplam leads to improved functional outcomes - 2 Minute Medicine
-
Treating spinal muscular atrophy before birth - Drug Discovery News
-
It's $2.5m a dose and it's giving some children another chance at life - Australian Broadcasting Corporation
-
Hope on the horizon: Science’s promise for spinal muscular atrophy - SMA News Today
-
Novartis’ Itvisma gets FDA approval for spinal muscular atrophy treatment - PMLiVE
-
Spinal Muscular Atrophy (SMA): Steven's Story (Video) - KidsHealth
-
Early treatment offers new hope for children with spinal muscular atrophy - UNSW Sydney
-
Newborn screening for spinal muscular atrophy in Ukraine: from pilot project to national programme - The Lancet
-
Biomarkers in spinal muscular atrophy - Frontiers
-
How to Level Up From Pediatric to Adult Care With SMA - HealthCentral
-
Leading the way in treatment of Spinal Muscular Atrophy - Phoenix Children's Hospital
-
Gestational Age at Birth and Clinical Manifestations of Spinal Muscular Atrophy - Neurology® Journals
-
Study: Apitegromab Meaningfully Improves Motor Function in Spinal Muscular Atrophy - Pharmacy Times
-
In utero ASO therapy for spinal muscular atrophy - Nature
-
Spinal Muscular Atrophy Functional Composite Score Revised (SMA-FCR) in Untreated and Nusinersen-Treated Patient Cohorts - Neurology® Journals
-
Coexisting Rheumatoid Arthritis and Spinal Muscular Atrophy: A Case Report - Cureus
-
Jesy Nelson celebrates plans for rollout of SMA screenings for newborn babies - Sky News
-
Research brings hope for new treatments for spinal muscular atrophy, autism - Medical Xpress
-
Combinatory Treatment to Alleviate Cellular Stress and Improve Skeletal Muscle Phenotype in Spinal Muscular Atrophy - American Heart Association Journals
-
Navigating SMA in a Relationship: Alyssa and Jason - biogen.com
-
Spinal muscular atrophy injection: Types and more - Medical News Today
-
Spinal Muscular Atrophy (SMA): Steven's Story (Video) (for Parents) - Children's WI - KidsHealth
-
Prenatal carrier screening for spinal muscular atrophy among pregnant Thai women - Frontiers
-
Spinal Muscular Atrophy (SMA): Steven's Story (Video) (for Parents) - Children's Nebraska - KidsHealth
-
Gene therapy improves movement in kids with spinal muscular atrophy - Scimex
-
DFW teen with spinal muscular atrophy aims for college basketball glory - cbsnews.com
-
Jesy Nelson feeling 'proud' after 'major milestone' announced amid her SMA campaigning - FemaleFirst
-
Overview of Spinal Muscular Atrophy - The American Journal of Managed Care® (AJMC®)
-
Setting Realistic Goals for Long-Standing Spinal Muscular Atrophy - NeurologyLive
-
Fatal outcomes following onasemnogene abeparvovec in advanced-stage spinal muscular atrophy | Gene Therapy - Nature
-
Early intervention is vital for children with SMA - Fieldfisher
-
Neonatal spinal muscular atrophy with brain magnetic resonance imaging hypersignal: a case report - Frontiers
-
“How I Found Love for My Body With Spinal Muscular Atrophy” - HealthCentral
-
Fiocruz and Hypera Pharma to produce medication for Spinal Muscular Atrophy - Fundação Oswaldo Cruz (Fiocruz)
-
Study shows clear efficacy of drug in adult patients with spinal muscular atrophy - MedUni Wien
-
First country in UK introduces newborn screening for rare condition - National Health Executive
-
Jesy Nelson SMA test victory as NHS rolls out baby checks for muscle wasting disease - The Mirror
-
Jesy Nelson ‘proud’ that SMA screenings to be rolled out in October - BreakingNews.ie
-
Leading comprehensive care for adults living with spinal muscular atrophy (SMA) - Sunnybrook Health Sciences Centre
-
Diving into progress: a review on current therapeutic advancements in spinal muscular atrophy - Frontiers
-
Risdiplam for Prenatal Therapy of Spinal Muscular Atrophy - NEJM
-
New Insights into the Origins of Spinal Muscular Atrophy - Columbia University Irving Medical Center
-
Spinal Muscular Atrophy Update in Best Practices - Neurology® Journals
-
New Therapeutic Strategies for Spinal Muscular Atrophy - Northwestern University
-
Spinal Muscular Atrophy Update in Best Practices | Neurology Clinical Practice - Neurology® Journals
-
Promising results from first prenatal therapy for spinal muscular atrophy - St. Jude Children's Research Hospital
-
She lost one son to a rare genetic disease – now her fourth child has it too: 'I want to hold on to hope' - CNA Lifestyle
-
Dubai hospital treats boy, 3, with pioneering spinal muscular atrophy drug in 'defining moment' - thenationalnews.com
-
Madhya Pradesh Infant Battles Rare Disease, Family Seeks Rs 9.4 Crore For Treatment - ETV Bharat
-
SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy - Nature
-
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy - NEJM
-
Risdiplam in Type 1 Spinal Muscular Atrophy - NEJM
-
Jesy Nelson hails 'massive' NHS SMA test announcement after twins' diagnosis - Birmingham Live
-
Parents of tots with same condition as Jesy Nelson's twins send star five-word message - The Mirror
-
Nusinersen Treatment in Adults With Spinal Muscular Atrophy - Neurology® Journals
-
Functional and structural analysis of SITTER patients with spinal muscular atrophy - Nature
-
Adult Spinal Muscular Atrophy Overview for Clinicians - MedCentral
-
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls - NEJM
-
Therapeutic strategy for spinal muscular atrophy by combining gene supplementation and genome editing - Nature
-
Spinal muscular atrophy - Nature
-
EXCLUSIVE: Jesy Nelson's ‘bittersweet’ moment as major SMA test update announced - The Mirror
-
Macrostructural Brain Abnormalities in Spinal Muscular Atrophy - Neurology® Journals
-
Identifying novel response markers for spinal muscular atrophy revealed by targeted proteomics following gene therapy - Nature
-
Nusinersen in later-onset spinal muscular atrophy - Neurology® Journals
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.